A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy

Abstract Background Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical...

Full description

Bibliographic Details
Main Authors: Fangyuan Zhang, Sumei Lv, Yating Feng, Xuan Yang, Wanmin Qiang
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Health Services Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12913-019-4539-6
id doaj-86fc346b6b4b45b09495848866adeddd
record_format Article
spelling doaj-86fc346b6b4b45b09495848866adeddd2020-11-25T03:57:46ZengBMCBMC Health Services Research1472-69632019-10-011911910.1186/s12913-019-4539-6A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapyFangyuan Zhang0Sumei Lv1Yating Feng2Xuan Yang3Wanmin Qiang4Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerForth Hospital of Hebei Medical UniversityThe First Affiliated Hospital of Zhengzhou UniversityTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for CancerAbstract Background Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical appraisal of the methodological quality of guidelines for the management of skin rash in patients on chemotherapeutic drugs and targeted anticancer therapies was undertaken, in order to identify appropriate ones for healthcare professionals. Methods A systematic search of databases and Internet was conducted to obtain pertinent guidelines. Two reviewers independently assessed the eligibility of guidelines according to the inclusion criteria. Then the guidelines included were appraised by three researchers with the methodological quality of eligible guideline using Appraisal of Guidelines for Research and Evaluation II (AGREEII). Results Totally nineteen guidelines met the inclusion criteria. The quality ranged from good to acceptable in scope and purpose (mean: 78.80%, range: 66.67–94.44%) and clarity of presentation domains (mean: 85.38%, 75.00–91.67%), but not in stakeholder involvement (mean: 50.15%, range: 36.11–75.00%), rigor of development (mean: 23.65%, range: 6.25–70.83%), applicability (mean: 23.96%, range: 4.17–52.08%), and editorial independence domains (mean: 45.18%, range: 0.00–87.50%). Overall, two guidelines were classified as “recommended”. Conclusions Only two guidelines were recommended to manage skin rash in patients on chemotherapy and targeted therapies, most guidelines issued were of low to moderate quality. Thus, more attention should be paid to the methodological quality of guideline development in this field.http://link.springer.com/article/10.1186/s12913-019-4539-6ChemotherapyTargeted therapyRashGuidelinesAGREE
collection DOAJ
language English
format Article
sources DOAJ
author Fangyuan Zhang
Sumei Lv
Yating Feng
Xuan Yang
Wanmin Qiang
spellingShingle Fangyuan Zhang
Sumei Lv
Yating Feng
Xuan Yang
Wanmin Qiang
A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
BMC Health Services Research
Chemotherapy
Targeted therapy
Rash
Guidelines
AGREE
author_facet Fangyuan Zhang
Sumei Lv
Yating Feng
Xuan Yang
Wanmin Qiang
author_sort Fangyuan Zhang
title A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
title_short A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
title_full A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
title_fullStr A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
title_full_unstemmed A technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
title_sort technical appraisal of guidelines for the management of skin rash in patients on chemotherapy and targeted therapy
publisher BMC
series BMC Health Services Research
issn 1472-6963
publishDate 2019-10-01
description Abstract Background Skin rash remains one of the most prevalent and troublesome clinical problems experienced by patients on chemotherapy and targeted therapy. To ensure high-quality care, guidelines are seen as the best guidance. Considering the quality of guidelines varies greatly, a systematical appraisal of the methodological quality of guidelines for the management of skin rash in patients on chemotherapeutic drugs and targeted anticancer therapies was undertaken, in order to identify appropriate ones for healthcare professionals. Methods A systematic search of databases and Internet was conducted to obtain pertinent guidelines. Two reviewers independently assessed the eligibility of guidelines according to the inclusion criteria. Then the guidelines included were appraised by three researchers with the methodological quality of eligible guideline using Appraisal of Guidelines for Research and Evaluation II (AGREEII). Results Totally nineteen guidelines met the inclusion criteria. The quality ranged from good to acceptable in scope and purpose (mean: 78.80%, range: 66.67–94.44%) and clarity of presentation domains (mean: 85.38%, 75.00–91.67%), but not in stakeholder involvement (mean: 50.15%, range: 36.11–75.00%), rigor of development (mean: 23.65%, range: 6.25–70.83%), applicability (mean: 23.96%, range: 4.17–52.08%), and editorial independence domains (mean: 45.18%, range: 0.00–87.50%). Overall, two guidelines were classified as “recommended”. Conclusions Only two guidelines were recommended to manage skin rash in patients on chemotherapy and targeted therapies, most guidelines issued were of low to moderate quality. Thus, more attention should be paid to the methodological quality of guideline development in this field.
topic Chemotherapy
Targeted therapy
Rash
Guidelines
AGREE
url http://link.springer.com/article/10.1186/s12913-019-4539-6
work_keys_str_mv AT fangyuanzhang atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT sumeilv atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT yatingfeng atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT xuanyang atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT wanminqiang atechnicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT fangyuanzhang technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT sumeilv technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT yatingfeng technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT xuanyang technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
AT wanminqiang technicalappraisalofguidelinesforthemanagementofskinrashinpatientsonchemotherapyandtargetedtherapy
_version_ 1724458742126215168